Intra-Cellular Therapies Inc 内部交易概览

最近18个月交易的高管股东
交易次数
净买入(股)
Mark Neumann10-181,034
Michael Halstead9-233,341
Sharon Mates9-554,970
Suresh K. Durgam9-129,431
Lawrence J. Hineline7-222,738
Joel S Marcus3-41,328
交易分段汇总
买入数量
卖出数量
净买入(股)
最近1个月000
最近3个月0237,827-237,827
最近6个月0687,688-687,688
最近12个月0969,077-969,077
最近18个月01,382,842-1,382,842
最近36个月01,458,006-1,458,006

Intra-Cellular Therapies Inc 内部交易

今年
1年
3年
5年
10年
15年
全部

Intra-Cellular Therapies Inc 最新内部交易


Lawrence J. Hineline
SVP of Finance, CFO
2024-03-11
卖出
23,253
-
$66.32
+7.37%
Suresh K. Durgam
EVP, Chief Medical Officer
2024-03-11
卖出
10,162
19,803
$66.21
+7.55%
Mark Neumann
EVP, Chief Commercial Officer
2024-03-11
卖出
20,477
29,700
$66.23
+7.52%
Michael Halstead
EVP & General Counsel
2024-03-11
卖出
20,477
-
$66.09
+7.75%
Sharon Mates
Chairman, President & CEO
2024-03-11
卖出
61,277
1,050,309
$66.07
+7.78%
Van Nostrand Robert L
董事
2024-02-27
卖出
20,000
9,611
$72.93
-2.36%
Mark Neumann
EVP, Chief Commercial Officer
2024-02-26
卖出
7,907
29,700
$70.13
+1.54%
Suresh K. Durgam
EVP, Chief Medical Officer
2024-02-26
卖出
4,112
9,488
$70.17
+1.48%
Sharon Mates
Chairman, President & CEO
2024-02-26
卖出
22,590
1,050,309
$69.79
+2.03%
Joel S Marcus
董事
2024-02-26
卖出
26,328
49,662
$68.68
+3.68%